As WHO Swine Flu advisors are revealed, PACE rapporteur renews call for greater transparency

13 August 2010

Paul Flynn (UK, SOC), former rapporteur of the Parliamentary Assembly of the Council of Europe (PACE) on the handling of the H1N1 pandemic, has welcomed this week's publication by the World Health Organization of the list of members of its Emergency Committee on the influenza pandemic, as well as their declarations of interest.

A day earlier, the WHO's Director General, Margaret Chan, announced that the phase 6 of influenza pandemic alert is now officially over, saying: 'We are now moving into the post-pandemic period. The new H1N1 virus has largely run its course.'

She explained that these are the views of members of the Emergency Committee, which based its assessment on the global situation, as well as reports from several countries that are now experiencing influenza. 'As we enter the post-pandemic period, this does not mean that the H1N1 virus has gone away. Based on experience with past pandemics, we expect the H1N1 virus to take on the behavior of a seasonal influenza virus and continue to circulate for some years to come,' Dr Chan stated.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical